Quality of life in Irritable Bowel Syndrome, effect of therapy

European Journal of Surgery, Supplement

Volumn 164, Issue 583, 1998, Pages 81-86

  Chassany, Olivier ^a   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Clinical trials; Functional digestive disorders; Irritable bowel syndrome; Quality of life; Treatment

Indexed keywords

ARTICLE; FUNCTIONAL DISEASE; IRRITABLE COLON; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT OUTCOME; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MALE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; COLONIC DISEASES, FUNCTIONAL; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0032216685     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 1992; 116: 1001-1008.
2. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 3-15.
3. Chang L. Evolving therapies for functional colonic disorders. Current Opinion in Gastroenterology 1996; 12: 32-38.
4. Chassany O, Geneve J, Abitbol JL, Scherrer B, Dapagny M, Fraitag B. Specific quality of life questionnaire in IBS. Effect of fedotozine. Gastroenterology 1995; 108 (Suppl): A581.
5. Chassany O, Bergmann JF, Marquis P, Scherrer B, Sapede C, Geneve J. Development and validation of a disease-specific quality of life instrument in functional digestive disorders. Therapie 1995; 50 (Suppl 1): A35.
6. Chassany O, Marquis P, Fraitag B, Scherrer B, Sapede C. European psychometric validation of a specific quality of life questionnaire in functional digestive disorders. Gut 1996; 99 (Suppl 3): A33.
7. Dapoigny M, Abitbol JL, Meric G, Geneve J, Fraitag B. Fedotozine in IBS: results of a 6 week placebo controlled multicenter therapeutic trial. Gastroenterology 1995; 108 (Suppl): A588.
8. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated, multicomponent treatment approach. Ann Intern Med 1992; 116: 1009-1016.
9. Drossman DA. The role of psychosocial factors in gastrointestinal illness. Scand J Gastroenterol 1996; 31 (Suppl 221): 1-4.
10. Fullerton S, Gitnick G. Health-related quality of life, patient outcome, and managed care: the road ahead. Scand J Gastroenterol 1996; 31 (Suppl 221): 39-41.
11. Fullerton SC. Health-related quality of life. Current Opinion in Gastroenterology 1996; 12: 39-43.
12. Glise H, Hallerbäck B, Wiklund I. Quality of life: a reflection of symptoms and concerns. Scand J Gastroenterol 1996; 31 (Suppl 221): 14-17.
13. Guyatt GH, Townsend M, Herman LB, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
14. Guyatt GH, Feeny DM, Patick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
15. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 547-552.
16. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11: 553-559.
17. Irvine EJ. Measuring quality of life: a review. Scand J Gastroenterol 1996; 31 (Suppl 221): 5-7.
18. King TS, Hunter JO. Quality of life in irritable bowel syndrome: does it improve with resolution of symptoms? Gastroenterology 1997; 112 (Suppl): A761.
19. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1998; 95: 232-241.
20. Mathias JR, Clench MH, Abell TE, et al. Effects of leuprolide acetate on functional bowel disease: a multicenter, double-blind, placebo-controlled study. Gastroenterology 1997; 112 (Suppl): A784.
21. Mory B, Poynard T, Naveau S, Chaput JC. Epidémiologie et méthodologie des essais thérapeutiques randomisés chez les sujets atteints de troubles fonctionnels intestinaux. Gastroenterol Clin Biol 1990; 14: 58C-64C. (In French).
22. O'Boyle C, McGee H, Hickey A, et al. Individual quality of life in patients undergoing hip-replacement. Lancet 1992; 339: 1088-1091.
23. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol a Biol Sci Med Sci 1995; 50: M184-M189.
24. Strassels SA, Hahn BA. Short form 36 (SP-36) scores in patients with IBS compared with US norms. Gastroenterology 1997; 112 (Suppl): A44.
25. Talley NJ, Phillips SF, Melton LJ, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-674.
26. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81.
27. Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248-2253.
28. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 27-40.